CIK 0001583771
- Non-accelerated filer
- Smaller reporting company
Hepion Pharmaceuticals, Inc.
Sign in to watch- Tickers
- HEPA CTRVP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462783806
- Phone
- +1 732-902-4000
- Business address
- 34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
- Former names
- ContraVir Pharmaceuticals, Inc.
Securities
- HEPA Common stock OTC
- CTRVP Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at an average $3.07 ($15,350)
- 4 Open-market buy Director bought 3,000 shares at an average $5.61 ($16,841)
- 4 Open-market buy CEO and Director bought 1,600 shares at $5.60 ($8,960)
- 4 Open-market buy CEO,CSO and Director bought 1,600 shares at $5.40 ($8,640)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $2.20 ($22,000)
- 4 Open-market buy CEO and Director bought 20,000 shares at $2.00 ($40,000)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $2.00 ($20,000)
Page 3 of 8 · 158 filings